Clinical Trial Update: Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 feasibility trial evaluating intraoperative detection of residual cancer in breast cancer patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Lumicell, Inc. | Conditions: Breast Cancer, Neoadjuvant Therapy | Phase 2 | Status: TERMINATED